Anti-CD23 monoclonal antibody inhibits germline Cepsilon transcription in B cells

Area of Science:

• Immunology
• Molecular Biology

Background:

• Immunoglobulin E (IgE) plays a key role in allergic reactions.
• CD23 is a low-affinity receptor for IgE involved in B cell activation and IgE production.
• Targeting IgE production is a therapeutic strategy for allergic diseases.

Purpose of the Study:

• To investigate the inhibitory effect of a chimeric macaque/human anti-CD23 antibody, p6G5G1, on IgE production.
• To elucidate the mechanism by which p6G5G1 inhibits IgE synthesis.
• To determine the optimal timing for p6G5G1 intervention.

Main Methods:

• Human peripheral blood mononuclear cells (PBMCs) were stimulated with IL-4 and anti-CD40.
• The effect of p6G5G1 on IgE production was measured.
• RNA analysis using RT-PCR and Northern blot was performed to assess germline Cepsilon RNA and CD23 mRNA levels.
• The impact of early versus late addition of p6G5G1 was evaluated.

Main Results:

• p6G5G1 significantly inhibited IL-4 and anti-CD40-stimulated IgE production in PBMCs.
• p6G5G1 suppressed germline Cepsilon RNA synthesis but did not affect CD23 mRNA levels.
• Early addition of p6G5G1 was critical for potent IgE inhibition.
• Later addition of p6G5G1 inhibited the upregulation of surface CD23.

Conclusions:

• The anti-CD23 antibody p6G5G1 inhibits IgE production by suppressing germline Cepsilon RNA synthesis.
• The timing of p6G5G1 administration influences its inhibitory effects on IgE and CD23.
• p6G5G1 shows potential as a therapeutic agent for IgE-mediated allergic conditions.